USA: 
Europe: 
Email: 
Consultation
| Catalog: | C0273T |
| Product Type: | Test kit |
| Tested parameter: | SARS-COV-2 |
| Assay time: | 20 min |
| Sample type: | cell |
| Application: | COVID-19, cell viability, for hematology |
ADAMII CD3/CD4/CD8 is the target of human T cell response to SARS-CoV-2, so it can be used for vaccine development and monitoring of COVID-19 patients. Vaccine injection triggers an immune response through CD4 T cells, so that understanding the dynamics of T cells is essential for vaccine development.
Diagnostic Development
Follow Us -
Copyright © 2024 Creative Bioarray. All rights reserved.
